Evidence map›Paper›PMID 37371796›Full record

ReviewBiomedicines2023

Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis.

Cinzia Garofalo, Costanza Maria Cristiani, Sara Ilari, Lucia Carmela Passacatini, Valentina Malafoglia, Giuseppe Viglietto, Jessica Maiuolo, Francesca Oppedisano, Ernesto Palma, Carlo Tomino and 3 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07738926 (A Prospective, Randomised, Controlled Crossover Study on the Effectiveness of Bifidobacterium Adolescentis PRL2019 in the Treatment of Juvenile Fibromyalgia), which is not on this map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07738926 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Prospective, Randomised, Controlled Crossover Study on the Effectiveness of Bifidobacterium Adolescentis PRL2019 in the Treatment of Juvenile Fibromyalgia

TypeinterventionalSponsorIstituto Giannina GasliniRan2026 to 2026Enrolled30ConditionsFibromyalgia, Fibromyalgia SyndromeArmsBifidobacterium adolescentis PRL2019, Placebo
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Cinzia GarofaloDepartment of Experimental and Clinical Medicine, "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.
Costanza Maria CristianiDepartment of Medical and Surgical Sciences, Neuroscience Research Center, "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-7811-2083
Sara IlariPhysiology and Pharmacology of Pain, IRCCS San Raffaele Roma, 00166 Rome, Italy.ORCID 0000-0002-6756-6530
Lucia Carmela PassacatiniDepartment of Health Science, Institute of Research for Food Safety & Health (IRC-FSH), "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.
Valentina MalafogliaPhysiology and Pharmacology of Pain, IRCCS San Raffaele Roma, 00166 Rome, Italy.
Giuseppe VigliettoDepartment of Experimental and Clinical Medicine, "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.
Jessica MaiuoloDepartment of Health Science, Institute of Research for Food Safety & Health (IRC-FSH), "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.
Francesca OppedisanoDepartment of Health Science, Institute of Research for Food Safety & Health (IRC-FSH), "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0003-0930-8987
Ernesto PalmaDepartment of Health Science, Institute of Research for Food Safety & Health (IRC-FSH), "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0003-4199-207X
Carlo TominoScientific Direction, IRCCS San Raffaele Roma, 00166 Rome, Italy.ORCID 0000-0003-1823-2195
William RaffaeliInstitute for Research on Pain, ISAL Foundation, Torre Pedrera, 47922 Rimini, Italy.
Vincenzo MollaceDepartment of Health Science, Institute of Research for Food Safety & Health (IRC-FSH), "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.
Carolina MuscoliDepartment of Health Science, Institute of Research for Food Safety & Health (IRC-FSH), "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-1047-4467
Magna Graecia University · ITVita-Salute San Raffaele University · ITFondazione ISAL · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine New Researcher 22-154Ministry of Education, Universities and Research PON03PE_00078_1Ministry of Education, Universities and Research PON03PE_00078_2
6 · The paper itself

Abstract

Fibromyalgia (FM) is a serious chronic pain syndrome, characterised by muscle and joint stiffness, insomnia, fatigue, mood disorders, cognitive dysfunction, anxiety, depression and intestinal irritability. Irritable Bowel Syndrome (IBS) shares many of these symptoms, and FM and IBS frequently co-exist, which suggests a common aetiology for the two diseases. The exact physiopathological mechanisms underlying both FM and IBS onset are unknown. Researchers have investigated many possible causes, including alterations in gut microbiota, which contain billions of microorganisms in the human digestive tract. The gut-brain axis has been proven to be the link between the gut microbiota and the central nervous system, which can then control the gut microbiota composition. In this review, we will discuss the similarities between FM and IBS. Particularly, we will focus our attention on symptomatology overlap between FM and IBS as well as the similarities in microbiota composition between FM and IBS patients. We will also briefly discuss the potential therapeutic approaches based on microbiota manipulations that are successfully used in IBS and could be employed also in FM patients to relieve pain, ameliorate the rehabilitation outcome, psychological distress and intestinal symptoms.

Indexed as

fibromyalgiaIBSmicrobiota gut-brain axis

Identifiers

PMID37371796
PMCPMC10296515
OpenAlexW4380483957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.